亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

隨州市紅旗化工有限公司  

醫(yī)藥原料醫(yī)藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁(yè) > 供應(yīng)產(chǎn)品 > 托吡酯CAS: 97240-79-4
托吡酯CAS: 97240-79-4
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號(hào) 97240-79-4
過期 長(zhǎng)期有效
更新 2020-06-18 10:08
 
詳細(xì)信息


托吡酯
CAS: 97240-79-4
別名:妥泰;2,3:4,5-雙-O-(1-甲基亞乙基)-β-D-吡喃果糖氨基磺酸酯
英文名稱:Topiramate
別名: 2,3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
分子式:C12H21NO8S
分子量:339.36
含量: 98.0%~102.0%,
標(biāo)準(zhǔn):USP31
外觀:本品應(yīng)為白色或類白色結(jié)晶性粉末
作用:醫(yī)藥中間體
包裝:25Kg/桶

©2025 隨州市紅旗化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:31417  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |